Browse drugs

… indicated that selected immune parameters may be influenced by glucocorticoid exposure and disease duration.Conclusions Patients with SLE wit…

…trexate use increased until 2020 and plateaued thereafter while tocilizumab prescriptions rose, reaching over 25% in 2022. Male sex and bas…

…mic Lupus International Collaborating Clinics damage index) and glucocorticoid (GC) exposure. A neurocognitive battery assessed executive func…

…nicity, age at diagnosis, disease duration, nephritis/NPSLE and glucocorticoid use.Results Of 224 patients with cSLE, 41% had documented ACEs.…

…ar disease, kidney failure, malignancy, pregnancy or lactation, diuretic or glucocorticoid use. Participants were classified as metaboli…

…topenias, high-titer ANA and anti-dsDNA led to SLE diagnosis so hydroxychloroquine and glucocorticoid were started. In 2014, due to high proteinur…

…in systemic lupus erythematosus (SLE) and different patterns of glucocorticoid (GC) dosing.Methods We studied a nationwide cohort of individua…

…8). Musculoskeletal and ophthalmologic domains, often linked to glucocorticoid exposure, contributed most to non-renal damage.Abstract S9:05 F…

…d users, mean cumulative dose was 1407 mg in the claims cohort. Hydroxychloroquine, methotrexate and mycophenolate were the most commonly used imm…

…tial for hypothetical tests to improve GCA diagnosis and reduce glucocorticoid toxicity, while demonstrating their market viability for use wi…

…S) complete remission at D/C (OR: 0.20, p=0.005) and persistent hydroxychloroquine use (OR: 0.28, p=0.031) protected against post-D/C renal flares…

…ue make it impractical for all patients. In this case, standard glucocorticoid and immunosuppressive therapies failed to halt disease progress…